Women 30% More Likely To Need Repeat Hip Implant Surgery

Did you know that hip replacements are more likely to fail in women?  Actually according to a new study, women are 30% more likely to need a repeat hip implant surgery within the first three years.

“It’s really an exciting paper,” said study co-author Dr. Art Sedrakyan, associate professor of public health at Weill Cornell Medical College in New York City. “What we’ve observed is regardless of size, women had a higher rate of revision occurrence.”

“This is the first step in what has to be a much longer-term research strategy to figure out why women have worse experiences,” said Diana Zuckerman, president of the nonprofit National Research Center for Women & Families, who wrote an accompanying editorial to this study in the same journal issue. “Research in this area could save billions of dollars” and prevent patients from experiencing the pain and inconvenience of surgeries to fix hip implants that go wrong.

For the study, Sedrakyan and his team looked at 35,140 surgeries at 46 hospitals in the Kaiser Permanente health system.

After an average of three years, 2.3 percent of the women and 1.9 percent of the men had undergone revision surgery to fix a problem with the original hip replacement. Problems for repeat hip implant surgery included instability, infection, broken bones and loosening.

Sedrakyan said the increased risk was only seen when the cause of rejection was aseptic, meaning not caused by infection, which suggests the problems were not related to issues during surgery. The most common problems that required another surgery were dislocation and wear of the product.

Then what explains the gender differences for repeat hip implant surgery?

Women tend to have smaller joints and bones than men, and so they tend to need smaller artificial hips. Devices with smaller femoral heads — the ball-shaped part of the ball-and-socket joint in an artificial hip – are more likely to dislocate and require a surgical repair.

That explained some, but not all, of the difference between women and men in the study.

Doctors traditionally believed the larger the size of the implant, the more protective it was against failure, according to Sedrakyan.  However, he said his study found regardless of size, women had a higher rate of repeat hip implant surgery, so some other factor besides the actual implants may be leading to this effect.

“I think there’s something beyond the use of the implants that seems to be related to this second surgery recurrence,” he said.

He thinks anatomy may play a role. Women have different pelvic and hip anatomy, he said and it’s also possible that some other unknown activities specific to women make them more vulnerable to a dislocation or higher wear.

Co-author Dr. Monti Khatod, an orthopedic surgeon in Los Angeles, speculated that one factor may be a greater loss of bone density in women.

Sedrakyan said that it’s premature to say women need different, more-specialized hip implants than men, because the overall risk remained low. He references past research on gender-specific knee implants, and how researchers learned they weren’t any more helpful.

“We shouldn’t jump to conclusions,” he said. “We need to understand this better.”

The research was published Feb. 18 in JAMA Internal Medicine, and was funded by the U.S. Food and Drug Administration.

, , , , , ,

No comments yet.

Leave a Reply

  • This field is for validation purposes and should be left unchanged.
Latest Drug Injury News

Paxil Possibly Linked To Breast Cancer Risk

Cancer researchers from the City of Hope National Medical Center announced a possible link between Paxil and breast cancer. Research focused on Paxil’s estrogen effect Researchers found that Paxil has a weak estrogen effect that could increase women’s breast cancer risks. According to lead author and chairman of City of Hope’s Department of Cancer and […]

Big Pharma under Fire for Kickbacks to Docs

Trust and honesty are the cornerstones to a doctor-patient relationship. With so many doctors receiving financial incentives to use certain medications or medical devices, patients need to know if money drives the decision making process. Doctors are required to disclose potential financial conflicts to each other at conferences, but there currently is no law forcing […]

Dietary Supplements Damage Liver

A recent study revealed a significant increase in liver damage related to dietary supplements. The study, conducted by a national network of liver specialists, found a 13% increase in serious liver damage over a 10 year span. Some of these patients required liver transplants and some have even died due to liver failure. Authors of […]

FDA Advisory Committee Supports Approval of Gilead’s HIV Reducing Drug

The pharmaceutical industry may be on the verge of one of the greatest breakthrough’s that this generation has ever seen.

U.S. Health Regulators Issue New Restrictions For Gilenya, Novartis AG’s’ Multiple Sclerosis Pill

In December 2011, the FDA issued a Drug Safety Communication concerning a patient with multiple sclerosis (MS) who died within 24 hours of taking the first dose of Gilenya (fingolimod).

Latest Medical Device Injury News

Report Raises Concerns Over Heart Defibrillator Leads

The Food and Drug Administration (FDA) has just announced that they received a report that a St. Jude Durata cardiac defibrillator lead conductor became externalized; meaning the wire carrying electricity from the heart defibrillator to the heart was exposed through its insulation, a potentially dangerous and life-threatening defect.

HeartSine Class 1 Defibrillator Recall

HeartSine sent out a letter to customers in September, warning that the defibrillators may intermittently turn on and off, eventually depleting the battery.

FDA Medical Device Approval Based On Little Evidence

More than half of the high-risk cardiovascular devices approved in the past decade had no supporting active control data.

St. Jude Medical Gets FDA Warning

St. Jude Medical Inc. said it received a FDA warning about manufacturing and quality-control problems at its Sylmar, California, plant.

Hospira Still Facing Manufacturing And Regulatory Issues

Hospira has sent out 11 device notifications so far in 2013, including recall and device corrections. The company also said it sent notices to customers about some of its infusion pumps that had to either be recalled, fixed or adjusted.